EUROPE COUGH SYRUP MARKET 2023-2030

Lifesciences | Pharmaceuticals

EUROPE COUGH SYRUP MARKET 2023-2030

Market by Product Type, Age Group, Distribution Channel, and Country Outlook | Forecast 2023-2030

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research report that the cough syrup market in Europe is estimated to progress in value at a CAGR of 3.65% during the forecast years 2023-2030.


Report scope can be customized per your requirements - Request Free Sample Report 

The countries assessed in the region consist of:

•         United Kingdom

•         Germany

•         France

•         Spain

•         Italy

•         Rest of Europe

The aging population in Europe is on the rise, leading to an increased occurrence of respiratory illnesses, particularly coughs and colds. This has led to a greater need for cough syrup as older individuals seek efficient solutions to alleviate their respiratory issues. Additionally, the presence of alternative treatment options like tablets, lozenges, and herbal remedies may influence consumer preferences away from the conventional cough syrups.

Germany dominates the region’s market with the highest share. The growing preference for over-the-counter (OTC) medications in Germany is primarily driven by the ease of access and convenience they offer. Cough syrups, for instance, can be readily found in both pharmacies and retail stores, eliminating the need for a doctor’s prescription. Additionally, as Germans increasingly prioritize their well-being and seek milder alternatives, herbal cough syrups have gained traction, further fueling the cough syrup market’s growth across the nation.

Similarly, over-the-counter cough syrups, readily accessible without a prescription, have garnered traction among individuals seeking respite from coughs and associated ailments in the UK. Their appeal is significantly boosted by the ease of acquisition through local pharmacies and retail establishments. Furthermore, the diverse selection of non-prescription cough and cold remedies within the UK often encompasses cough syrups designed to address distinct symptoms, be it dry or chesty coughs, thereby opening avenues for the studied market.

Retail pharmacies offer a diverse array of cough syrups, providing consumers with a range of choices to address their specific needs. They typically stock both prescription and over-the-counter (OTC) cough syrups. Besides, they are strategically positioned in neighborhoods and commercial hubs, ensuring easy accessibility for consumers.

The market is segmented into distribution channel, age group, and product type. The distribution channel includes retail, hospital, and e-pharmacies.

The major firms in the market include Cipla Limited, Acella Pharmaceuticals LLC, Sanofi SA, AstraZeneca Plc, Kenvue Inc, and The Himalaya Wellness Company.

Sanofi is involved in researching, developing, manufacturing, and promoting pharmaceutical products, primarily in the prescription sector. Additionally, the company creates over-the-counter medications. Sanofi’s focus encompasses seven key therapeutic domains: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. The company operates actively in over 135 countries, with headquarters located in Paris, France.

 

Key deliverables of the report:

·       Market CAGR during the forecasting years 2023-2030

·       Detailed data highlighting key insights, industry components, and market strategies

·       Comprehensive information and estimation of the cough syrup market revenue growth in Europe and its influence on the parent market

·       In-depth study of forthcoming trends in consumer behavioral patterns

·       A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

·       A wide-ranging study of factors that will challenge the Europe cough syrup market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE COUGH SYRUP MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT ANALYSIS ON THE COUGH SYRUP MARKET

2.1.1. COVID-19 IMPACT

2.1.2. UKRAINE-RUSSIA WAR IMPACT

2.2. PORTER’S FIVE FORCES ANALYSIS

2.2.1. THREAT OF NEW ENTRANTS

2.2.2. THREAT OF SUBSTITUTES

2.2.3. BARGAINING POWER OF BUYERS

2.2.4. BARGAINING POWER OF SUPPLIERS

2.2.5. THREAT OF COMPETITIVE RIVALRY

2.3. INDUSTRY COMPONENTS

2.3.1. RAW MATERIALS

2.3.2. MANUFACTURERS

2.3.3. DISTRIBUTORS

2.3.4. RETAILERS

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET STRATEGIES

2.5.1. COLLABORATIONS

2.5.2. PRODUCT LAUNCHES

2.5.3. ACQUISITIONS

2.5.4. BUSINESS DIVESTITURES & EXPANSIONS

2.6. MARKET DRIVERS

2.6.1. HIGH INCIDENCE OF RESPIRATORY AILMENTS

2.6.2. VULNERABILITY TO RESPIRATORY DISEASES AMONG THE GERIATRIC POPULATION

2.6.3. INNOVATIONS IN COUGH SYRUPS

2.7. MARKET CHALLENGES

2.7.1. OVERDOSE RISKS ASSOCIATED WITH COUGH SYRUPS

2.7.2. STRICT REGULATORY REQUIREMENTS

2.7.3. INCREASING COUGH SYRUP DEATHS DUE TO TOXIC INGREDIENTS

2.8. MARKET OPPORTUNITIES

2.8.1. SELF-MEDICATION TRENDS INCREASE DEMAND FOR OTC DRUGS

2.8.2. HERBAL COUGH SYRUPS EMERGE AS A SAFER ALTERNATIVE

2.8.3. EASE OF PURCHASE OFFERED BY E-COMMERCE CHANNELS

2.8.4. AVAILABILITY OF SUGAR-FREE COUGH SYRUPS

2.8.5. GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.9. ANALYST PERSPECTIVE

3. EUROPE COUGH SYRUP MARKET – BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS

3.2. COMBINATION MEDICINES

3.3. EXPECTORANTS

4. EUROPE COUGH SYRUP MARKET – BY AGE GROUP

4.1. ADULTS

4.2. ADOLESCENTS

4.3. PEDIATRIC

5. EUROPE COUGH SYRUP MARKET – BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACIES

5.2. HOSPITAL PHARMACIES

5.3. E-PHARMACIES

6. EUROPE COUGH SYRUP MARKET – BY COUNTRY OUTLOOK

6.1. UNITED KINGDOM

6.1.1. UNITED KINGDOM COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2. GERMANY

6.2.1. GERMANY COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3. FRANCE

6.3.1. FRANCE COUGH SYRUP MARKET FORECAST & PROSPECTS

6.4. ITALY

6.4.1. ITALY COUGH SYRUP MARKET FORECAST & PROSPECTS

6.5. SPAIN

6.5.1. SPAIN COUGH SYRUP MARKET FORECAST & PROSPECTS

6.6. REST OF EUROPE

6.6.1. REST OF EUROPE COUGH SYRUP MARKET FORECAST & PROSPECTS

7. COMPETITIVE LANDSCAPE

7.1. GSK PLC

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY STRENGTHS

7.1.4. KEY CHALLENGES

7.2. PFIZER INC

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY STRENGTHS

7.2.4. KEY CHALLENGES

7.3. NOVARTIS AG

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY STRENGTHS

7.3.4. KEY CHALLENGES

7.4. RECKITT BENCKISER GROUP PLC

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY STRENGTHS

7.4.4. KEY CHALLENGES

7.5. THE PROCTER & GAMBLE COMPANY

7.5.1. OVERVIEW

7.5.2. PRODUCT PORTFOLIO

7.5.3. KEY STRENGTHS

7.5.4. KEY CHALLENGES

7.6. SANOFI SA

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY STRENGTHS

7.6.4. KEY CHALLENGES

7.7. CIPLA LIMITED

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY STRENGTHS

7.7.4. KEY CHALLENGES

7.8. KENVUE INC

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY STRENGTHS

7.8.4. KEY CHALLENGES

7.9. ASTRAZENECA PLC

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY STRENGTHS

7.9.4. KEY CHALLENGES

7.10. ACELLA PHARMACEUTICALS

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY STRENGTHS

7.10.4. KEY CHALLENGES

7.11. THE HIMALAYA WELLNESS COMPANY

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY STRENGTHS

7.11.4. KEY CHALLENGES

7.12. MERCK KGAA

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY STRENGTHS

7.12.4. KEY CHALLENGES

7.13. ABBOTT LABORATORIES

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY STRENGTHS

7.13.4. KEY CHALLENGES

7.14. GLENMARK PHARMACEUTICALS LIMITED

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY STRENGTHS

7.14.4. KEY CHALLENGES

7.15. DABUR INDIA LTD

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY STRENGTHS

7.15.4. KEY CHALLENGES

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: EUROPE COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: LIST OF COLLABORATIONS

TABLE 4: LIST OF PRODUCT LAUNCHES

TABLE 5: LIST OF ACQUISITIONS

TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS

TABLE 7: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 8: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 9: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

TABLE 10: EUROPE COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

List of Figures

FIGURE 1: INDUSTRY COMPONENTS

FIGURE 2: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)

FIGURE 3: EUROPE COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)

FIGURE 4: EUROPE COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)

FIGURE 5: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2022 & 2030 (IN %)

FIGURE 6: EUROPE COUGH SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)

FIGURE 7: EUROPE COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)

FIGURE 8: EUROPE COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)

FIGURE 9: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN %)

FIGURE 10: EUROPE COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 11: EUROPE COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 12: EUROPE COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 13: EUROPE COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)

FIGURE 14: UNITED KINGDOM COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 15: GERMANY COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 16: FRANCE COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 17: ITALY COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 18: SPAIN COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 19: REST OF EUROPE COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying